Intratympanic corticosteroids vs no treatment or versus placebo
Proportion of patients whose hearing is improved · sudden sensorineural hearing loss
Intratympanic corticosteroids may leads to higher proportion of patients whose hearing is improved compared with no treatment or versus placebo (low certainty).
1 finding from 1 review
- Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes onlyRR 5.55 [2.89, 10.68]6 studies · 232 participantsLow